BioCentury
ARTICLE | Clinical News

Aczone dapsone topical gel regulatory update

March 24, 2008 7:00 AM UTC

FDA approved an sNDA from QLT to update the label for Aczone to remove the glucose 6-phosphate dehydrogenase ( G6PD) screening and blood monitoring requirements. The topical 5% dapsone gel is marketed...